ALX Nigeria has unveiled Creative Tech Lite, a new initiative designed to equip the continent’s creators with in-demand digital skills. Touted as a game-changer for Africa’s creative economy ...

The launch event, held at ALX Nigeria’s flagship hub in Costain, Lagos, brought together industry leaders, creators, and community figures to celebrate a transformative initiative set to enhance ...

Country General Manager, ALX Nigeria, Ruby Igwe said: “Creative Tech Lite is our way of saying every skill set matters in the future of work.Whether you are creating beats, telling stories ...

Just over a month after laying off staff to focus on its lead cancer candidate, ALX Oncology announced that the asset failed to meet the primary endpoints of two phase 2 trials and is scrapping ...

ALX Oncology’s CD47-blocker evorpacept, in combination with MSD’s blockbuster Keytruda (pembrolizumab), has failed to show benefit in two Phase II trials. The combination was being ...

ALX Oncology (ALXO) announced receipt of U.S. Food and Drug Administration clearance for the Investigational New Drug application for ALX2004, the company’s antibody-drug conjugate for the ...

ALX Oncology ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary ...

ALX Oncology (ALXO) announced “encouraging” data from an ongoing Phase 1/2 investigator-sponsored trial of the company’s lead clinical candidate, evorpacept, in combination with standard-of ...

And it works. Ruby Igwe, a ViMP alumna, now leads as Country General Manager at ALX Nigeria, where she’s building Africa’s next generation of digital talent and reimagining access to tech ...